AWM
IBB icon

Apollon Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Apollon Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
8,118
-288
-3% -$49.5K 0.02% 573
2026
Q1 		$1.42M Sell
8,406
-50
-0.6% -$8.55K 0.02% 475
2025
Q4 		$1.43M Sell
8,456
-173
-2% -$28.1K 0.02% 463
2025
Q3 		$1.25M Buy
8,629
+111
+1% +$15.2K 0.02% 511
2025
Q2 		$1.08M Sell
8,518
-236
-3% -$29K 0.02% 530
2025
Q1 		$1.12M Buy
8,754
+96
+1% +$13K 0.02% 480
2024
Q4 		$1.14M Buy
8,658
+1,195
+16% +$168K 0.03% 468
2024
Q3 		$1.09M Sell
7,463
-1,539
-17% -$223K 0.03% 461
2024
Q2 		$1.24M Sell
9,002
-175
-2% -$23.4K 0.04% 401
2024
Q1 		$1.26M Buy
9,177
+926
+11% +$126K 0.04% 405
2023
Q4 		$1.12M Sell
8,251
-295
-3% -$36K 0.04% 415
2023
Q3 		$1.05M Sell
8,546
-1,558
-15% -$198K 0.05% 349
2023
Q2 		$1.28M Buy
10,104
+1,029
+11% +$134K 0.06% 324
2023
Q1 		$1.17M Sell
9,075
-1,131
-11% -$148K 0.07% 288
2022
Q4 		$1.34M Sell
10,206
-239
-2% -$30.9K 0.1% 225
2022
Q3 		$1.22M Buy
10,445
+83
+0.8% +$10.3K 0.1% 214
2022
Q2 		$1.22M Sell
10,362
-364
-3% -$43.2K 0.1% 222
2022
Q1 		$1.4M Buy
10,726
+7,249
+208% +$944K 0.1% 212
2021
Q4 		$530K Buy
3,477
+61
+2% +$9.44K 0.04% 451
2021
Q3 		$552K Buy
3,416
+319
+10% +$53.7K 0.08% 248
2021
Q2 		$507K Sell
3,097
-86
-3% -$13.2K 0.09% 214
2021
Q1 		$479K Buy
+3,183
New +$506K 0.09% 206
2020
Q3 		– Sell
-393
Closed -$54K – 385
2020
Q2 		$54K Buy
+393
New +$50.1K 0.03% 235

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Apollon Wealth Management's IBB Position: Q2 2026 in Review

Apollon Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 3.4% in Q2 2026, selling an estimated $49.5K and leaving 8,118 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #573.

Apollon Wealth Management first reported a position in IBB in Q2 2020 and has held it in 23 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Apollon Wealth Management held 8,118 shares of iShares Biotechnology ETF worth $1.54M as of Q2 2026.
  • Apollon Wealth Management sold 288 iShares Biotechnology ETF shares in Q2 2026, an estimated $49.5K.
  • iShares Biotechnology ETF made up 0.02% of Apollon Wealth Management's portfolio in Q2 2026, its #573 holding.
  • Apollon Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 23 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.